Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial
| Autor: | Aroda, Vanita R, Bain, Stephen C, Cariou, Bertrand, Piletič, Milivoj, Rose, Ludger, Axelsen, Mads, Rowe, Everton, DeVries, J Hans |
|---|---|
| Zdroj: | In The Lancet Diabetes & Endocrinology May 2017 5(5):355-366 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|